10. Income taxes
The following table summarizes the income tax recognized in profit or loss for the years ended 31 December 2022 and 2021.
|
Year ended 31 December |
|
|---|---|---|
(thousands of €) |
2022 |
2021 |
Current tax |
(4,071) |
(2,020) |
Deferred tax |
1,227 |
(404) |
Total income taxes |
(2,844) |
(2,423) |
Current tax, consisting of corporate income taxes, and deferred tax income/cost (–) related to subsidiaries working on a cost plus basis. In addition, the deferred tax income for the year ended 31 december 2022 was largely due to the partial release of the net deferred tax liabilities related to the acquisitions of CellPoint and AboundBio.
Tax liabilities
The below table illustrates the tax liabilities related captions in the consolidated statement of financial position as at 31 December 2022 and 2021.
|
31 December |
|
|---|---|---|
(thousands of €) |
2022 |
2021 |
Current tax payable |
1,022 |
1,782 |
Total tax liabilities |
1,022 |
1,782 |
On 31 December 2022, the tax liabilities were primarily related to our subsidiaries operating on a cost plus basis.
Taxes recognized in profit or loss
For the purpose of the disclosure below corporate tax was calculated at 25% (2021: 25%) – which is the tax rate applied in Belgium – on the estimated assessable profit for the year. The applied tax rate for other territorial jurisdictions was the tax rate that is applicable in these respective territorial jurisdictions on the estimated taxable result of the accounting year.
|
Year ended 31 December |
|
|---|---|---|
(thousands of €) |
2022 |
2021 |
Loss before tax |
(215,147) |
(122,999) |
Income tax debit/credit (-), calculated using the Belgian statutory tax rate on the accounting profit/loss (-) before tax (theoretical) |
(53,787) |
(30,750) |
Tax expenses in income statement (effective) |
2,844 |
2,423 |
Difference in tax expenses/income to explain |
56,631 |
33,173 |
|
|
|
Effect of tax rates in other jurisdictions |
(337) |
(582) |
Effect of non-taxable revenues |
(7,642) |
(9,413) |
Effect of share-based payment expenses without tax impact |
22,127 |
17,682 |
Effect of expenses/income (-) not subject to tax |
(146) |
(907) |
Effect of non-tax-deductible expenses |
3,224 |
3,812 |
Effect of recognition of previously non recognized deferred tax assets |
(1,677) |
(1,411) |
Effect of tax losses (utilized) reversed |
- |
(404) |
Effect from under or over provisions in prior periods |
1,101 |
(840) |
Effect of non-recognition of deferred tax assets |
38,104 |
25,613 |
Effect of derecognition of previously recognized deferred tax assets |
1,877 |
135 |
Effect of use of investment deduction |
- |
(512) |
Total explanations |
56,631 |
33,173 |
Non-taxable revenues for the years ended 31 December 2022 and 2021 were related to non-taxable subsidies and tax credits.